Construction and Verification of a Predictive Nomogram for Overall Survival in Patients with Large Retroperitoneal Liposarcoma: A Population-Based Cohort Study
Current Oncology · 2025
DOI: 10.3390/curroncol32080473 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Current Oncology, 2025. Verfasst von Huan Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Peking University First Hospital, Beijing 100034, China. Hauptthemen laut MEDLINE: Nomograms, Retroperitoneal Neoplasms, Liposarcoma. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to show the clinicopathological characteristics of large retroperitoneal liposarcoma (RLS) and to develop a customized nomogram model for patients with large RLS.
Methods
A total of 1735 patients diagnosed with RLS were selected from the public SEER database. Among them, 1113 patients with a maximum tumor diameter greater than 150 mm were included for further analysis. Nomogram models were developed based on Lasso and multivariate Cox regression analyses. A total of 166 patients that presented in the same period at our institution were used for external validations.
Results
A larger tumor size in RLS was associated with worse survival outcomes. Lasso and Cox regression analyses consistently identified age, TNM stage, occurrence pattern, histology, and surgery as important prognostic factors for OS. The constructed model demonstrated robust predictive performance, with better time-ROC (time-dependent receiver operating characteristic) for 1-year (83.1%), 3-year (83.8%), and 5-year (81.4%) survival in the training cohort. The concordance index (C-index) was approximately 0.80 in both the training and validation cohorts, reflecting excellent discriminatory ability of the model. Survival risk stratification analysis revealed significant differences in survival outcomes of large RLS (HR = 4.12 [3.31–5.12], p < 0.001, in the training cohort). Decision curve analysis (DCA) confirmed that the nomogram provided greater net benefits across a range of threshold probabilities.
Conclusion
This study identified important prognostic factors for survival in patients with large RLS and developed a reliable nomogram for predicting OS. The model’s strong predictive performance supports its use in personalized treatment strategies, improving prognosis assessment and clinical decision making for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Peking University First Hospital, Beijing 100034, China.
- Department of General Surgery, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zitieren
APA
Deng, H., Lu, Z., Wang, Y., Xiao, L., & Pan, Y. (2025). Construction and Verification of a Predictive Nomogram for Overall Survival in Patients with Large Retroperitoneal Liposarcoma: A Population-Based Cohort Study. Current Oncology. https://doi.org/10.3390/curroncol32080473
Vancouver
Deng H, Lu Z, Wang Y, Xiao L, Pan Y. Construction and Verification of a Predictive Nomogram for Overall Survival in Patients with Large Retroperitoneal Liposarcoma: A Population-Based Cohort Study. Current Oncology. 2025. doi:10.3390/curroncol32080473
BibTeX
@article{Deng2025,
author = {Deng, Huan and Lu, Zhenhua and Wang, Yajie and Xiao, Lin and Pan, Yisheng},
title = {Construction and Verification of a Predictive Nomogram for Overall Survival in Patients with Large Retroperitoneal Liposarcoma: A Population-Based Cohort Study},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32080473}
}
EUVIMED